Ayres J G, Miles J F, Barnes P J
Heartlands Research Institute, Birmingham Heartlands Hospital, UK.
Thorax. 1998 Apr;53(4):315-21. doi: 10.1136/thx.53.4.315.
We believe that the asthma phenotypes we have defined as types 1 and 2 brittle asthma appear to be defined subgroups of asthma. For example, we have characterised patients with type 1 brittle asthma, as defined in this review, on the basis of peak flow variability and treatment and these patients remain a separate group when assessed by other means such as psychosocial factors, immunoglobulin levels, and atopy. The question remains as to whether they are truly separate groups with entirely different pathogenetic influences or whether they simply represent the severe end of the spectrum. Our suggested classification into types 1 and 2 forms a useful start for studies of this condition, although prospective evaluation of patients with severe asthma is the only way of substantiating the validity of these definitions which will then enable investigation of possible mechanisms. However, these patients are rare and in order to study them as a group a national register would need to be set up along the lines of the West Midlands Brittle Asthma Register, perhaps recruiting all "at risk" patients and then using this resource as a means of exploring the different asthma phenotypes within this broad grouping, including brittle asthma.
我们认为,我们定义为1型和2型脆性哮喘的哮喘表型似乎是哮喘的特定亚组。例如,根据本综述中对1型脆性哮喘的定义,我们已根据峰值流量变异性和治疗方法对患者进行了特征描述,当通过其他方式(如心理社会因素、免疫球蛋白水平和特应性)进行评估时,这些患者仍然是一个独立的群体。问题仍然存在,即它们是真正具有完全不同致病影响的独立群体,还是仅仅代表了疾病谱的严重一端。我们建议的1型和2型分类为该疾病的研究提供了一个有用的开端,尽管对重度哮喘患者进行前瞻性评估是证实这些定义有效性的唯一方法,这将能够对可能的机制进行研究。然而,这些患者很罕见,为了将他们作为一个群体进行研究,需要按照西米德兰兹脆性哮喘登记处的模式建立一个全国性登记处,或许招募所有“有风险”的患者,然后利用这一资源来探索这一广泛分组中的不同哮喘表型,包括脆性哮喘。